CASI Pharmaceuticals, Inc. - Ordinary Share (CASI)

Historical Holders from Q4 2022 to Q3 2025

Symbol
CASI on Nasdaq
CUSIP
G1933S101
Type / Class
Equity / Ordinary Share
Shares outstanding
20.5M
All holders as of September 30, 2025
Q3 2025
Total 13F shares, excl. options
2.61M
Holdings value
$4.33M
% of all portfolios
0%
Grand Portfolio weight change
+0%
Number of holders
21
Number of buys
6
Number of sells
-7
Average Value change %
+0%
Average buys %
+0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of CASI Pharmaceuticals, Inc. - Ordinary Share (CASI)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
He Wei-Wu 23.8% $7.51M 3.74M WEI-WU HE, Ph.D. Jun 16, 2025
Panacea Innovation Ltd 19.9% $8.38M 3.66M James Huang Sep 26, 2025
Chen Zhenfeng M 11% $4.15M 2.26M Chen Zhenfeng Sep 30, 2025
Huang James 13.8% $3.18M 2.16M James Huang Jun 30, 2025
Ho Chi Sing 6.4% $2M 993K Quan Zhou Dec 30, 2024
Foresite Capital Fund VI LP 6.3% +24% $1.63M $320K 980K +24.5% Foresite Capital Fund VI LP Sep 30, 2025

Institutional Holders of CASI Pharmaceuticals, Inc. - Ordinary Share (CASI)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 2.61M $4.33M +$649K $1.66 21
2025 Q2 2.25M $2.65M -$589K $1.18 23
2025 Q1 2.74M $5.93M +$186K $2.16 22
2024 Q4 2.66M $7.52M -$53.8K $2.83 22
2024 Q3 1.32M $8.14M +$5.98M $6.16 20
2024 Q2 352K $1.94M +$552K $5.50 23
2024 Q1 250K $903K -$261K $3.61 19
2023 Q4 276K $1.98M -$339K $7.16 17
2023 Q3 345K $883K -$269K $2.56 18
2023 Q2 450K $1.12M -$1.18M $2.50 18
2023 Q1 930K $2.15M +$2.15M $2.32 19
2022 Q4 100 $179 +$179 $1.79 1